Etanercept

Details

Files

Generic Name:

Etanercept

Project Status:

Complete

Therapeutic Area:

Rheumatoid arthritis, Ankylosing spondylitis

Manufacturer:

Merck Canada Inc.

Call for patient/clinician input open:

March 9, 2016

Brand Name:

Brenzys

Project Line:

Reimbursement Review

Project Number:

SE0485-000

Call for patient/clinician input closed:

April 28, 2016

NOC Status at Filing:

Pre NOC

Biosimilar:

Yes

Submission Type:

Initial

Indications:

Rheumatoid arthritis, ankylosing spondylitis

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

October 25, 2016

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Patient Group Input Submissions View PDF

Subsequent Entry Biologic Review Report View PDF

Last Updated : March 9, 2016